A Study to Test How Well BI 3000202 is Tolerated by People With Type 1 Interferonopathies

BI 3000202_low doseOngoingActive not recruitingPhase 1Open NCT06878365 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…